Atogepant reduced migraine days during the perimenstrual period, positioning the medication as a potential first treatment option for the condition.
|Articles|October 18, 2007
Coalition wants e-prescribing in Medicare to be mandatory by 2010
Groups press for e-prescribing in Medicare.
Advertisement
A broad coalition of consumer, union, business, and purchaser groups is urging Congress to make e-prescribing in Medicare mandatory for all doctors by 2010. In a letter to Congressional committee leaders, the coalition urged policymakers to implement a safety requirement that
Advertisement
Related to this article
Chad Worz, PharmD, BCGP, FASCP, discusses the Main Street Pharmacy Access Act, a revolutionary pharmacy-focused bill moving through Congress.
Data show that commercially and Medicaid-insured children with chronic or immunocompromising conditions incur 2- to 3-fold higher costs.
Researchers assess the neurological outcomes of over 200,000 children exposed to COVID-19 before birth.
Results show consistent improvements in wakefulness, cataplexy, and quality of life with oveporexton for patients with narcolepsy.
Researchers assess the differences in out-of-pocket spending on brand name compared with generic medication.
Practical takeaways to improve real‑world clinic outcomes for PAINWeek 2026.
Starting with Exelixis’ condition on in-house dispensing data, manufacturers are introducing a new approach to 340B claims focused on transparency.
Advertisement
Advertisement
Trending on Drug Topics
1
Johnson & Johnson Next Major Drugmaker to Require 340B Claims Data
2
Study Finds No Neurodevelopmental Risk in Prenatal COVID-19, Except Speech
3
Generic Drug Costs Burdening Patients as Much as Brand Name Options
4
How the Main Street Pharmacy Access Act Advances Pharmacist Provider Status
5